Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamase-producing

Fatemeh Zangane Matin1, Seyedeh Elham Rezatofighi2, Mohammad Roayaei Ardakani1

  • 1Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, 6135743135, Ahvaz, Iran.

Abstract

Insights

Carbapenem-resistant Uropathogenic Escherichia coli (UPEC) producing metallo-beta-lactamases (MBLs) are a growing global health threat. These resistant strains, carrying genes like blaNDM and blaOXA-48, can readily transfer resistance via plasmids.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Uropathogenic Escherichia coli (UPEC) causes frequent urinary tract infections (UTIs).
  • Antimicrobial resistance (AMR), particularly carbapenem resistance (CR), poses a significant global health challenge.
  • Metallo-beta-lactamases (MBLs) are key enzymes conferring resistance to carbapenems.

Purpose of the Study:

  • To investigate the characteristics of MBL-producing UPEC isolates.
  • To identify the prevalence of MBL genes and virulence factors in CR UPEC.
  • To assess the transferability of carbapenem resistance among UPEC strains.

Main Methods:

  • Cross-sectional study of UPEC isolates from October 2018 to December 2019 in Ahvaz, Iran.
  • Detection of MBL production using modified carbapenem inactivation (mCIM) and EDTA-CIM (eCIM) tests.
  • Molecular identification of MBL, phylogenetic, and virulence genes; conjugation assays; plasmid profiling; and ERIC-PCR for clonal analysis.

Main Results:

  • 12 (2.95%) of 406 UPEC isolates were carbapenem-resistant, with 11 being MBL-producing.
  • Prevalent MBL genes included blaNDM (9 isolates) and blaOXA-48 (5 isolates).
  • Key virulence genes identified were traT, fyuA, fimH, and iutA; CR was transferable via plasmids.

Conclusions:

  • The rapid spread of MBL and carbapenemase genes (e.g., blaNDM, blaOXA-48) in UPEC presents a global public health threat.
  • Continuous monitoring of emerging AMR is crucial for updating antimicrobial therapy guidelines.
  • Understanding resistance and virulence mechanisms is vital for developing novel therapeutic strategies against CR UPEC.

Related Concept Videos

Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...